ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0071

Stage-Specific Roles of Interleukin-23/Interleukin-17 Axis and Type 1 Regulatory T Cells Dynamics in Axial Spondyloarthritis

Jina Yeo1, Min-Gang Kim2, Hee Sung Kwon3, Mi Ryoung Seo1, Hyo-Jin Choi1, YunJae Jung4, Eun Young Lee5 and Han Joo Baek6, 1Division of Rheumatology, Department of Internal Medicine, Gil Medical Center, Gachon University College of Medicine, Incheon, Republic of Korea, 2Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea, 3Division of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea, 4Department of Microbiology, College of Medicine, Gachon University, Incheon, Republic of Korea, 53Division of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea, 6Division of Rheumatology, Department of Internal Medicine, Gil Medical Center, Gachon University College of Medicine, Inchon, South Africa

Meeting: ACR Convergence 2024

Keywords: cytokines, Dendritic cells, spondyloarthritis, T Cell

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 16, 2024

Title: SpA Including PsA – Basic Science Poster

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: The interleukin (IL)-23/IL-17 pathway is central to axial spondyloarthritis (axSpA) pathogenesis, yet treatments targeting IL-23 show inconsistent effectiveness across spondyloarthritis subtypes. We hypothesized that the IL-23/IL-17 axis varies with disease stage and is influenced by regulatory counterparts, such as type 1 regulatory T (Tr1) cells.

Methods: We assessed the levels of IL-17A and IL-23 in serum and the fraction of CD4+IL-17A+ cells, monocytes (CD14+HLR-DR+), DCs (CD11c+HLA-DR+), and type 1 regulatory T cells (Tr1, CD4+CD49b+LAG3+FoxP3–IL-10+) in peripheral blood obtained from patients with axSpA using enzyme-linked immunosorbent assay and flow cytometry. We also assessed the production of IL-17A from CD4+ T cells from healthy controls following co-culture with monocyte-derived DCs (moDCs) from patients with nr-axSpA compared with those from patients with r-axSpA.

Results: Blood samples from 20 nr-axSpA and 24 r-axSpA patients were analyzed. Serum IL-23 was significantly higher in nr-axSpA patients (p = 0.014), while IL-17A was similar in both groups (p = 0.792). Monocytes and DCs from nr-axSpA produced more IL-23 (p = 0.028 for monocyte, and p = 0.010 for DC), but there were no significant differences in Th17 cells between the groups (p > 0.05). moDCs from nr-axSpA patients stimulated higher proinflammatory cytokine production in CD4+ T cells from healthy controls compared to those from r-axSpA (p < 0.05). Notably, Tr1 cells were significantly lower in nr-axSpA (p = 0.025), and IL-10 treatment reduced IL-23 production by moDCs from nr-axSpA but not from r-axSpA.

Conclusion: IL-23 might play a pathogenic role only in the early disease of axSpA, and IL-17 might be dissociated from IL-23 in advanced disease with enhanced IL-10 producing Tr1 cells as a regulatory counterpart, which requires further elucidation.


Disclosures: J. Yeo: None; M. Kim: None; H. Kwon: None; M. Seo: None; H. Choi: None; Y. Jung: None; E. Lee: None; H. Baek: None.

To cite this abstract in AMA style:

Yeo J, Kim M, Kwon H, Seo M, Choi H, Jung Y, Lee E, Baek H. Stage-Specific Roles of Interleukin-23/Interleukin-17 Axis and Type 1 Regulatory T Cells Dynamics in Axial Spondyloarthritis [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/stage-specific-roles-of-interleukin-23-interleukin-17-axis-and-type-1-regulatory-t-cells-dynamics-in-axial-spondyloarthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/stage-specific-roles-of-interleukin-23-interleukin-17-axis-and-type-1-regulatory-t-cells-dynamics-in-axial-spondyloarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology